Please login to the form below

Not currently logged in
Email:
Password:

WE UK

This page shows the latest WE UK news and features for those working in and with pharma, biotech and healthcare.

NICE recommends Chiesi’s alpha-mannosidosis enzyme replacement therapy

NICE recommends Chiesi’s alpha-mannosidosis enzyme replacement therapy

Dr Kamran Iqbal, head of medical affairs, global rare diseases, Chiesi UK and Ireland, said: “We are pleased that eligible patients in England and Wales will now be able to access ... The discovery and availability of new treatment options is crucial

Latest news

More from news
Approximately 0 fully matching, plus 318 partially matching documents found.

Latest Intelligence

  • Man vs microbe: the fight against antimicrobial resistance Man vs microbe: the fight against antimicrobial resistance

    One payer based in the UK remarked: “[The UK subscription model] hopefully means we can restrict use without detriment to development.” Another said: “I personally think that restricting use whilst encouraging ... The white paper includes data

  • Reimbursement ≠ patient access Reimbursement ≠ patient access

    In extreme cases we are seeing charities provide bursaries to hospitals to ensure patients receive new therapies. ... How do we do this? The simple answer is to demonstrate our commitment to value-based healthcare.

  • The fight against antimicrobial resistance The fight against antimicrobial resistance

    Point of care CRP tests are one of the most effective tools we have against unnecessary antibiotic prescribing in primary care. ... Point of care CRP testing has demonstrated its efficacy in a number of pilot projects in the UK.

  • How early-stage clinical research is facilitating the new wave of personalised medicines How early-stage clinical research is facilitating the new wave of personalised medicines

    We are fortunate that, in the UK, the government and the NHS committed early to embedding a personalised medicine approach across the health system. ... More than this, we have been crucial to their development. I’ve undertaken hundreds of clinical

  • Alzheimer’s disease: the search for a cure Alzheimer’s disease: the search for a cure

    We do this through a range of initiatives, including the Dementia Consortium and the Alzheimer’s Research UK Drug Discovery Alliance. ... This will determine whether this drug is licensed in the US, but for the UK we will have to wait longer and see

More from intelligence
Approximately 0 fully matching, plus 56 partially matching documents found.

Latest appointments

  • Diane DiGangi Trench appointed as country head of Sandoz UK Diane DiGangi Trench appointed as country head of Sandoz UK

    Sandoz, the generics division of Novartis, has announced the appointment of Diane DiGangi Trench as its new UK country head. ... I am delighted to join the UK organisation as Country Head as we celebrate our 15 years in biosimilar medicines,” commented

  • AstraZeneca taps internal candidate to become UK president AstraZeneca taps internal candidate to become UK president

    Keith-Roach joins the AZ UK team following a number of in-country, above-country and global therapy area leadership positions. ... I’m very pleased to join our team in the UK. We have a deep-rooted presence here at the heart of the UK life sciences

  • Pfizer’s Alan Maine moves to Edelman Pfizer’s Alan Maine moves to Edelman

    Prior to his time with Pfizer, Maine was head of government affairs at Wyeth Pharmaceuticals - later acquired by Pfizer - and has held other roles withmanaging director for Edelman UK, said: “We ... are very excited about Alan joining Edelman as he

  • WE UK appoints Catherine Devaney as head of health WE UK appoints Catherine Devaney as head of health

    Public relations group WE UK has appointed Catherine Devaney to head up its health sector business to bolster the agency’s global health offering. ... Marcus Sorour, general manager at WE UK, said: “The momentum we are experiencing in our health

  • Executive Insight strengthens UK presence with new partner Executive Insight strengthens UK presence with new partner

    Andrea Sobrio, managing partner, Executive Insight, said: “With his extensive background, David is well positioned to play an integral role in growing the group’s practice for UK-based international clients. ... We are honoured to welcome David to

More from appointments
Approximately 1 fully matching, plus 19 partially matching documents found.

Latest from PMHub

  • Could femtech be the answer to the gender health gap? Could femtech be the answer to the gender health gap?

    33. Within the UK at least, we are increasingly seeing more and more women in the public eye open up about their experiences with women’s health: including television presenter Naga ... 40. Will we see femtech branch out even further to fill this gap?

  • EU Joint Clinical Assessment (JCA) – implications for Pharma and Medtech

    We work closely with our clients, becoming an extension of their teams, to ensure the value of their products is appropriately communicated. ... Please email  info@mtechaccess.co.uk to discuss how we can support you with your JCA dossier.

  • nspm

    nspm is a successful and dynamic medical communications company with offices in Switzerland and the UK. ... We provide a complete range of medical writing, project management and strategic medical communications solutions for the pharmaceutical and

  • Flexible working: a fad or the future?

    As the Flexible Working Bill gets written into UK law, we took a look at what this means for businesses of all sizes and specialities. ... We’ve seen this with our own team and we’re excited to see how this new bill will help reshape the working

  • Article: War in the Blood - The battle takes shape in the burgeoning European oncology CAR-T market access space

    The filmmakers followed two leukaemia patients in first-in-human trials in the UK. ... To complement our review, we reached out to 12 payers in our network with advanced therapy expertise from across the UK, France, Germany, Spain, and Italy.

More from PMHub
Approximately 0 fully matching, plus 96 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Grace Communications

We’re an independent healthcare brand communications agency with a host of awards that speak to our success. Combining razor-sharp insights...

Latest intelligence

New Playbook Alert: Virtual Patient Engagement
...
Millennials: the wellness generation
Looking at the results from a global healthcare research study focusing on the patients of the future...
The problem with clinical trials (and how virtual insight-gathering can help)
While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....